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Abstract
Purpose: Our aim was to study the blood oxygen-carry-
ing function during the oxidative stress with a modification 
of the L-arginine-NO pathway. 
Material and methods: Oxidative stress was induced by 
intravenous administration of Escherichia coli lipopolysac-
charide (LPS) to rabbits. To modify the L-arginine-NO path-
way, animals were administered with NG-nitro-L-arginine 
methyl ester intravenously 60 min after the LPS. Mixed 
venous blood was sampled for evaluation of blood oxygen 
transport before and at 120 and 240 min after the LPS 
administration; tissue samples (heart, lung, liver, kidney 
and muscle) were also prepared. The following parameters 
were measured hemoglobin-oxygen affinity, concentrations 
of conjugated dienes, Schiff bases, -tocopherol and activity 
of catalase. 
Results: During the NO synthase inhibition the oxida-
tive stress was characterized by a shift of hemoglobin oxygen 
dissociation curve rightwards, more prominent activation of 
lipid peroxidation and decreased tissue levels of antioxidant 
defense factors. 
Conclusions: The inhibition of NO generation induces 
a  shift of prooxidant-antioxidant balance – obviously, not 
only due its potentially high levels and reactivity with the 
various target molecules (with a development of oxidative 
stress), but also because of the lower contribution of other 
factors including the hemoglobin-oxygen affinity change 
into the body antioxidant potential.
Key words:  oxidative stress, lipopolysaccharide, blood, 
nitric oxide.
Introduction
Under the tissue steady-state conditions, the excessive 
oxidant generation is counterbalanced by enzymatic and non-
enzymatic antioxidants inside and outside the cells; thus the 
some optimal level of prooxidant-antioxidant balance is created 
[1]. If this balance is changed due to the excessive free radical 
production and/or antioxidant system damage, the so-called 
oxidative stress appears. Under this condition the excessive free 
radical generation and non-specific tissue impairment occur 
without a  control by antioxidant mechanisms [2]. Experimental 
evidence suggests that reactive oxygen species may be important 
mediators of cellular injury during endotoxemia (induced by 
LPS), either as a result of macromolecular damage or by inter-
fering with extracellular and intracellular regulatory processes 
[3]. 
Nitric oxide (NO) is thought to play a key role in the 
pathogenesis of sepsis. Bacterial endotoxin induces the release 
of many mediators, including NO, responsible for a late-phase 
hypotension, vasoplegy, acidosis, hypoxia and multiorgan failure 
[4,5]. NO is an important participant of this complex system of 
prooxidant-antioxidant balance. NO is a free radical capable 
both to ameliorate the oxidative injury (as a chain-terminating 
radical scavenger) and to be the source of reactive nitrogen 
species [6]. NO has the complex relationships with the free 
oxygen radicals – both interaction (NO can react with O2
*– to 
generate a potent oxidant peroxynitrite) and competition (with 
a development of oxidative or nitrosative stress in the biological 
compartment) [7]. In a recent time the interactions between NO 
and hemoglobin (Hb) were extensively investigated. Three main 
NO-derivatives of Hb are known: methemoglobin, nitrosylhe-
moglobin (HbFe2+NO), and S-nitrosohemoglobin (SNO-Hb) 
[8-10]. In a molecule of HbFe2+NO the NO moiety is a ligand 
to ferrous heme, and SNO-Hb is a result of NO interaction with 
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cysteine (93) of -globin chain [11,12]. The presence of different 
hemoglobin-NO adducts can differently influence on the whole 
blood hemoglobin-oxygen affinity (HOA). Methemoglobin 
and SNO-Hb raise the HOA and HbFe2+NO decreases it. 
Such modulation of the blood oxygen-binding properties may 
be important for gas exchange and tissue oxygenation [13,14]. 
Our aim was to study the blood oxygen-carrying function during 
the oxidative stress with a modification of the L-arginine-NO 
pathway.
Material and methods
Animals
The adult male Chinchilla rabbits (n=21; body weight 
2.5-3.1 kg) were kept for 2 weeks in a constant-climate environ-
ment with respect to temperature, humidity and daylight cycle. 
Animals were fed on a laboratory diet with water and food ad 
libitum until use and fasted overnight with free access to water 
before the operation. Operation procedures were performed 
between 8.00 and 12.00 to avoid the chronobiological variations. 
All the experimental procedures described in this paper are in 
accordance with the Guiding Principles for the Care and Use of 
Animals accepted by the Ethical Committee of Grodno Medical 
University. 
Procedure
Animals were anesthetized with pentobarbital sodium (50 
mg/kg). Sham-operated rabbits (1st group) received 1.0 mL 
saline intravenously (n=5) served as a control for mixed venous 
blood and tissue sampling. In rabbits of the 2nd group (n=9) 
the oxidative stress was induced by intravenous administration 
of 500 g/kg Escherichia coli lipopolysaccharide (LPS) from 
Sigma Chemical. Animals of the 3rd group (n=7) intravenously 
received NO synthase inhibitor NG-nitro-L-arginine methyl 
ester (L-NAME) from Sigma Chemical, 7.5 mg/kg, 60 min after 
the LPS. The catheters for mixed venous blood sampling were 
inserted into the right atrium through the external jugular vein. 
Blood was collected in heparinized syringes. Such sampling for 
estimation of the blood oxygen transport was performed before 
and at 120 and 240 min after the LPS administration. Tissue 
sampling (heart, lung, liver, kidney and muscle) was performed 
after 240 min of oxidative stress; tissues were washed with a cold 
phosphate-buffered saline to remove the blood traces, and then 
the samples were immediately frozen in liquid nitrogen and 
stored until analysis.
Lipid peroxidation products 
Conjugated diene content was determined by the fluores-
cence intensity of UV absorption at 232-234 nm, characteristic 
for the conjugated diene structures [15]. Schiff base level was 
evaluated by the fluorescence intensity of chloroform extract at 
excitation and emission wavelengths of 344 and 440 nm, respec-
tively [15] with a spectrofluorimeter “F-4010” (Hitachi). 
Antioxidant system
-tocopherol content was measured by the fluorescence 
intensity of heptane extract at excitation and emission wave-
lengths of 292 and 325 nm, respectively [16] with a spectrofluo-
rimeter “F-4010” (Hitachi), using -tocopherol (Sigma) as 
a reference. Catalase activity in the biological materials was 
estimated by the decrease of hydrogen peroxide capable to form 
a stable stained complex with molybdenum salts, with a spectro-
photometer “C -46” at 410 nm [16]. 
Blood oxygen-carrying function 
pO2 were measured with micro gas analyzer ABL-330 
(Radiometer) at 37°C with the following correction to actual 
temperature value. HOA was evaluated by p50 (blood pO2 at its 
50% oxygen saturation) determined by the “mixing” method at 
37°C, pH 7.4 and pCO2 40 mm Hg (p50stand) [17]. p50 at actual 
pH, pCO2 and temperature (p50act) was calculated from p50stand 
with Severinghaus’ formulas [18] using the temperature coef-
ficient of 0.024. Oxygen dissociation curves of Hb (ODCs) were 
calculated with Hill’s equation using n=2.8. The amounts of Hb 
and methemoglobin were determined spectrophotometrically.
Measurement of plasma NO
3
 –/NO
2
 – 
Plasma samples (50 l) were deproteinized by incubation 
with 140 l of deionized H2O and 10 l of 30% ZnSO4 at room 
temperature for 15 min. Samples were then centrifuged at 
2 000 g for 10 min. Nitrate was converted to nitrite using cad-
mium beads, and nitrite was measured spectrophotometrically 
[19].
 
Statistical analysis
The data were statistically evaluated by Student’s t-test with 
a significance level of p<0.05. The results are presented as mean 
± standard error of mean (SE). The analyses and graphs were 
performed using computer software packages.
Results
LPS administration resulted into the prominent activation of 
lipid peroxidation processes, with a creation of oxidative stress. 
Tissue lipid peroxidation activity increased after LPS adminis-
tration – Fig. 1 (conjugated dienes in heart, lung, liver, kidney 
and muscle: by 38.8, 39.2, 48.9, 16.4 and 20.0%, respectively; 
Schiff bases: by 11.7, 60.1, 309.2, 69.5 and 60.7%, respectively; 
all p<0.05). The largest rises in conjugated diene and Schiff 
base content under oxidative stress (LPS + L-NAME) compar-
ing with only LPS injection were noted in lungs (16.2 and 14.7%, 
respectively; both p<0.05) and liver (54.3 and 20.6%, respec-
tively; both p<0.05). This indicates a higher activity of the free 
radical lipid oxidation during NO synthase inhibition. 
The lowering of the antioxidant defense factors was observed 
in tissues. Catalase activity and -tocopherol content in the lung 
of rabbits with oxidative stress (LPS) were significantly lower 
than in control – by 24.6 and 18.3%, respectively (all p<0.05); 
in liver the catalase activity decreased only by 6.9% (p<0.05). 
Under NO synthase inhibition such fall of antioxidant defense 
factors comparing with LPS group was even more significant in 
all tissues tested (Fig. 2). 
The content of NO utilization products (NO3
–/NO2
–) after 
LPS administration was larger than at baseline level; and 
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administration of L-NAME after LPS increased it at 120 min 
(less than after LPS only) and at 240 min (Tab. 1). 
The blood oxygen-binding properties considerably changed 
after the endotoxin administration (Tab. 1). Oxidative stress 
was accompanied by a development of hypoxia, even more 
marked during the NO synthase inhibition. The value of p50stand 
decreased at 120 and 240 min by 9.7 (p>0.05) and 10.6% 
(p<0.05), respectively. Meanwhile, p50act rose at 240 min after 
LPS by 9.3% (p<0.05) because of the changes in pH, pCO2 and 
body temperature. After the injection of L-NAME the values 
of p50act increased by 31.3 and 29.5% (both p<0.001) after 120 
and 240 min of oxidative stress, respectively, reflecting the more 
prominent shift of actual ODCs rightwards (Fig. 3).
Discussion
One can see that oxidative stress combined with NO 
synthase inhibition was characterized by the actual ODC shift 
rightwards, more marked lipid peroxidation activation and low-
ering of antioxidant defense factors in blood and tissues. Hb is 
an allosterically regulated protein and therefore has many bind-
ing sites capable to form the reversible non-covalent bonds with 
a primary ligands that can result in quaternary conformational 
changes and their modulation by the secondary effectors [13]. 
In our investigations the ODC position is dictated by effects of 
pH, pCO2 and other factors; but one should take in account also 
NO and its interactions with Hb. NO is considered as the ligand 
determining the Hb oxygen-binding properties [14]. 
Intraerythrocyte interaction between NO and Hb is impor-
tant for regulation of the both molecules in vivo. The red cell 
properties do not limit such interaction under the physiologic 
conditions [20]. In arterial blood the reaction between NO and 
oxyhemoglobin produces nitrate and methemoglobin, and in 
venous blood HbFe2+NO is generated; under high pO2 it can be 
oxidated to met-Hb and NO3
– [21,22]. The NO-binding site at
-globin chain was also found; such binding results in SNO-Hb 
[11]. The value of p50 for extracellular SNO-Hb is less than 
10  mm Hg [23], and p50 for HbFe2+NO is 39.6±1.5 mm Hg [24]. 
In our experiments the lowest ODC shift leftwards was observed 
in animals received L-arginine and exposed to hypothermia [1]. 
NO can affect tissue oxygenation through its influence on 
HOA and blood flow regulation. Simultaneously the mecha-
nisms of O2 transport (including the blood oxygen-binding prop-
erties) can modify the activity of the L-arginine-NO pathway. 
NO can modify HOA through the intraerythrocytic regulatory 
Figure 1. Indices of lipid peroxidation in rabbit tissues under the 
oxidative stress induced by LPS combined with administration of 
NG-nitro-L-arginine methyl ester (L-NAME): conjugated dienes 
(A), Schiff bases (B). The values are means ±SE. * – significant 
difference from the control group (p<0.05); # – significant dif-
ference from the group of rabbits received LPS (p<0.05)
Figure 2. The changes in catalase activity (A) and -tocopherol 
content (B) in rabbit tissues under the oxidative stress induced 
by LPS combined with administration of NG-nitro-L-arginine 
methyl ester (L-NAME). The values are means ±SE. * – signifi-
cant difference from the control group (p<0.05); # – significant 
difference from the group of rabbits received LPS (p<0.05)
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mechanisms, oxygen-dependent nature of NO production, gene-
ration of different NO-Hb derivatives [14]. The concentrations 
of NO and its derivatives in the microcirculatory part of vascular 
bed must be much higher than in larger vessels (100-fold and 
more). NO fraction directly interacting with Hb must also be 
higher. At the microcirculatory level this may be very important 
for the change of oxyhemoglobin binding and ultimately for the 
tissue oxygenation. NO can react with O2
*– to generate a potent 
oxidant peroxynitrite that can modify the Hb properties [6,7]. 
Hb may also defend against peroxynitrite, thereby functioning 
as an intracellular antioxidant. This may also be important for 
the modification of Hb function and its involvement in forma-
tion of O2 flux to tissues and in maintenance of the body prooxi-
dant-antioxidant balance [1].
Oxidative stress may be considered as the defect of aerobic 
metabolism – the stochastic process of a free radical production 
and non-specific tissue damage without the regulation by anti-
oxidant defense mechanisms [2]. Interactions between NO and 
free oxygen radicals creates the definite balance (O2
*– scavenger 
system competes with NO for the ONOO– generation) result-
ing in the oxidative stress development in a biological object 
[7]. The HOA change can regulate the oxygen flux to tissues 
according to requirements, thus preventing its excessive use for 
the free radical oxidation; therefore, HOA may be considered 
as one of the factors participating in maintenance of body 
prooxidant-antioxidant balance. During the oxidative stress the 
HOA changes mediated by NO-dependent mechanisms (in first 
turn, endothelial) can affect the oxygen flux to tissues and body 
prooxidant-antioxidant balance as a whole. Inhibition of NO 
synthesis induces a shift of this balance – obviously, not only 
because of potentially high NO levels and reactions with the 
diverse target molecules, but also due to the lower contribution 
of other factors including HOA in the antioxidant defense of 
body. These data support the notion that HOA may alter tissue 
oxygen supply and may be involved in the pathogenesis of oxida-
tive stress induced by administration of LPS. 
Acknowledgement
This work was supported by a grant from the Fund of Fun-
damental Investigations of the Republic of Belarus.
References
11. Zinchuk VV, Dorokhina LV, Maltsev AN. Prooxidant-antioxi-
dant balance in rats under hypothermia combined with modified hemo-
globin-oxygen affinity. J Therm Biol, 2002; 27: 345-52.
12. Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. 
Reactive oxygen species, cell signaling, and cell injury. Free Radic Biol 
Med, 2000; 28: 1456-62.
13. Cadenas S, Cadenas AM. Fighting the stranger – antioxidant 
protection against endotoxin toxicity. J Toxicology, 2002; 180: 45-63.
14. Wolkow PP. Involvement and dual effects of nitric oxide in 
septic shock. Inflamm Res, 1998; 47: 152-66.
Table 1. The changes NO3 
–/NO2 
– and indices of blood oxygen-
carrying function in rabbits during the oxidative stress induced 
by LPS combined with administration of NG-nitro-L-arginine 
methyl ester (L-NAME)
Index Baseline
After 
120 min 240 min
oxidative stress (LPS) 
n 9 9 9
NO3
–/NO2
–
 , M 6.11±0.36 11.41±0.52* 14.27±0.44*#
p50act, mm Hg 35.5±0.77 37.1±1.48 38.8±1.13*
p50stand, mm Hg 31.0±1.14 28.0±0.53* 27.7±0.91*
Hb, g/dL 9.72±0.20 9.33±0.20 9.30±0.21
pO2, mm Hg 33.78±2.23 30.94±2.50 28.12±1.34*
methemoglobin, % 0.28±0.09 0.88±0.11* 0.72±0.07*
pH, units 7.322±0.015 7.191±0.035* 7.137±0.037*
pCO2, mm Hg 47.56±3.12 38.21±2.47* 43.39±1.33
HCO3
-, mM 24.11±1.08 14.20±1.03* 14.28±0.94*
TCO2, mM 25.43±1.09 15.37±1.04* 15.51±0.89*
ABE, mM -1.97±1.37 -12.83±1.43* -13.71±1.47*
SBC, mM 22.46±1.11 13.81±1.01* 13.14±1.22*
oxidative stress (LPS+L-NAME)
n 8 8 7
NO3
–/NO2
–
 , M 6.11±0.26 8.95±0.52* 13.83±0.67*#
p50act, mm Hg 33.9±0.95 44.5±2.14* 43.9±1.32*
p50stand, mm Hg 31.4±0.74 31.3±0.90 29.8±0.74
Hb, g/dL 10.25±0.25 10.05±0.20 9.99±0.27
pO2, mm Hg 31.60±2.01 26.15±2.21 20.89±3.04*
methemoglobin, % 0.28±0.08 0.56±0.07* 1.07±0.10*#
pH, units 7.353±0.020 7.103±0.040* 7.029±0.023*
pCO2, mm Hg 48.65±3.87 47.21±3.36 61.54±2.80*#
HCO3
-, mM 26.63±1.80 14.27±1.95* 14.75±1.73*
TCO2, mM 28.11±1.85 15.53±1.93* 16.37±1.59*
ABE, mM 0.98±1.73 -14.98±2.69* -16.46±1.90*
SBC, mM 24.13±1.65 12.88±2.11* 9.06±1.69*
Note: Data are expressed as mean ±SE.
Significant difference (p<0.05) from the baseline level (*) and after 
the 120 min of received LPS (#)
Figure 3. Actual oxyhemoglobin dissociation curves for mixed 
venous blood in rabbits during the oxidative stress induced 
by LPS combined with administration of NG-nitro-L-arginine 
methyl ester
100 
90 
80 
60 
50 
40 
30 
20 
10 
0
pO2, mmHg
sO
2,
 %
0 20 40 60 80 100 120
Baseline             after 120 min             after 240 min
Ре
по
зи
то
ри
й Г
рГ
М
У
250 Glebov A, Zinchuk V 251Blood oxygen-carrying function during the oxidative stress induced by lipopolysaccharide with a modification of the L-arginine-NO pathway
15. Bateman RM, Sharpe MD, Ellis CG. Bench-to-bedside review: 
microvascular dysfunction in sepsis-hemodynamics, oxygen transport, 
and nitric oxide. Crit Care, 2003; 7: 359-73.
16. Klatt P, Lamas S. Regulation of protein function by S-gluta-
thiolation in response to oxidative and nitrosative stress. Eur J Biochem, 
2000; 267: 4928-44.
17. Esprey MG, Miranda KM, Feelisch M, Fukuto J, Grisham MB, 
Vitek MP, Wink DA. Mechanisms of cell death governed by the balance 
between nitrosative and oxidative stress. Ann NY Acad Sci, 2000; 899: 
209-21.
18. Gladwin MT, Ognibene FP, Pannell LK, Nichols JS, Pease-Fye 
ME, Shelhamer JH, Schechter AN. Relative role of heme nitrosylation 
and beta-cysteine 93 nitrosation in the transport and metabolism of nitric 
oxide by hemoglobin in the human circulation. Proc Natl Acad Sci USA, 
2000; 97: 9943-8.
19. Joshi MS, Ferguson TB, Han TH, Hyduke DR, Liao JC, Rassaf 
T, Bryan N, Feelisch M, Lancaster JR. Nitric oxide is consumed, rather 
than conserved, by reaction with oxyhemoglobin under physiological 
conditions. Proc Natl Acad Sci USA, 2002; 99: 10341-6.
10. Crawford JH, White CR, Patel RP. Vasoactivity of S-nitrosohe-
moglobin: role of oxygen, heme, and NO oxidation states. Blood, 2003; 
101: 4408-15.
11. Stamler JS, Jia L, Eu JP, McMahon TJ, Demchenko IT, 
Bonaventura J, Gernert K, Piantadosi CA. Blood flow regulation by S-
nitrosohemoglobin in the physiological oxygen gradient. Science, 1997; 
276: 2034-7.
12. Gladwin MT, Wang X, Reiter CD, Yang BK, Vivas EX, Bona-
ventura C, Schechter AN. S-Nitrosohemoglobin is unstable in the reduc-
tive erythrocyte environment and lacks O2/NO-linked allosteric function. 
J Biol Chem, 2002; 277: 27818-28.
13. Zinchuk V, Borisiuk V. The effect of NO synthase inhibition 
on blood oxygen-carrying function during hyperthermia in rats. Respir 
Physiol, 1998; 113: 39-45.
14. Zinchuk VV, Dorokhina LV. Blood oxygen transport in rats 
under hypothermia combined with modification of the L-arginine-NO 
pathway. Nitric Oxide, 2002; 6: 29-34.
15. Rice-Evans CA, Diplock AT, Symons MCR. Laboratory tech-
niques in biochemistry and molecular biology: techniques in free radical 
research. Elsevie, 1991; 125-44.
16. Aruoma OI, Cuppett SL. Antioxidant Methodology: in vivo and 
in vitro. Concepts AOCSPress, 1997; 152-86.
17. Scheid P, Meyer M. Mixing technique for study of oxygen-
hemoglobin equilibrium: A critical evaluation. J Appl Physiol, 1978; 45: 
616-22.
18. Severinghaus JW. Blood gas calculator. J Appl Physiol, 1966; 21: 
1108-16.
19. Schulz K, Kerber S, Kelm M. Reevaluation of the Griess 
method for determining NO3
–/NO2
– in aqueous and protein-containing 
samples. Nitric Oxide, 1999; 3: 225-34.
20. May JM, Qu ZC, Xia L, Cobb CE. Nitrite uptake and metabo-
lism and oxidant stress in human erythrocytes. Am J Physiol Cell, 2000; 
279: 1946-54.
21. Wennmalm A, Benthin G, Edlund A, Jungersten L, Kieler-
Jensen N, Lundin S, Westfelt UN, Petersson AS, Waagstein F. Metabo-
lism and excretion of nitric oxide in humans. Circ Res, 1993; 73: 1121-7.
22. Schechter AN, Gladwin MT. Hemoglobin and the paracrine and 
endocrine functions of nitric oxide. N Engl J Med, 2003; 348: 1483-5.
23. Bonaventura C, Feruzzi G, Tesh S, Stevens RD. Effects of S-nit-
rosation on oxygen binding by normal and sickle cell hemoglobin. J Biol 
Chem, 1999; 274: 24742-8.
Ре
по
зи
то
ри
й Г
рГ
М
У
